OR WAIT null SECS
September 02, 2023
The ACT EU initiative aims to develop the European Union further as a competitive centre for innovative clinical research.
August 02, 2023
What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?
July 02, 2023
Changes to PRIME scheme are set to drive greater harmonization across major pharmaceutical markets.
June 02, 2023
What implications will EMA’s recent regulatory reform have on pharma?
May 02, 2023
A strategy on cyber resilience for health and social care organizations has been set out by the UK government.
April 02, 2023
Proposed regulatory changes signal a major overhaul of legislation governing pharmaceuticals and healthcare in Spain.
March 02, 2023
Stepwise paediatric investigation plans aim to boost the development of medicines for children.
February 13, 2023
Pseudoephedrine is an oral treatment that can be used alone or in combination with other medicines to treat nasal congestion resulting from a cold, flu, or allergy.
February 02, 2023
A new unified initiative for patent protection in the EU to boost the competitiveness of the pharma industry is nearing completion.
January 02, 2023
Does the new regulatory framework have the potential to incentivise R&D investment in rare diseases?